Total Number of Communication Reports: 4
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Health
|
Food and Drugs Regulations, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
|
Policies or Program, Regulation
|
Health
|
Health Canada guidelines and administrative practices with respect to the approval, regulation and life-cycle management of therapeutic products
|
Policies or Program
|
Health
|
Health system policies with respect to pharmaceuticals, including drugs for rare diseases
|
Policies or Program
|
Address:
100 King Street West, Suite 5600
Toronto, ON M5X 1C9
Canada
Telephone number:
877-412-4775
Web address:
https://www.mt-pharma-ca.com/
Louise St-Onge, Associate Director, Market Access
Mitsubishi Tanabe Pharma Canada Inc. is not a coalition.
The activities of Mitsubishi Tanabe Pharma Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Mitsubishi Tanabe Pharma Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Stephen Sampson | Public offices held
Firm: Global Public Affairs